WAG

[al7bebe]

اعلان ارتفاع مداخيل الشركة الطبية

Estimate of $0.77; revenues rose 0.8%​

​

7:36AM Walgreens beats by $0.01, reports revs in-line with preannouncement (WAG)​

34.37 : Reports Q2​

e​

(F​

b) earnings of $0.78 per share,​

$0.01 better than​

the Capital IQ Consensus Estimate of $0.77; revenues rose 0.8% year/year to $18.65 bln vs the $18.47 bln consensus. Front-end comparable store sales increased 2.1% in the second quarter, customer traffic in comparable stores increased 0.7% and basket size increased 1.4%, while total sales in comparable stores decreased 1.5%. All second-quarter comparable store sales and prescription figures include 29 days in February 2012. Prescription sales, which accounted for 61.0% ​

Pre-Market: ​

34.98​

​

0.61 (1.77%)​

8:44AM EDT​

- Nasdaq Real Time Price​

rev Close:

34.37​

Open:

N/A​

Bid:

35.00 x 900​

Ask:

35.05 x 200​

1y Target Est:

36.24​

Beta:

1.25​

Next Earnings Date:

N/A​

​

​

Day's Range:

N/A - N/A​

52wk Range:

30.34 - 45.34​

Volume:

50,442​

Avg Vol (3m):

8,741,380​

Market Cap:

30.02B​

P/E (ttm):

11.63​

EPS (ttm):

2.96​

Div & Yield:

0.90 (2.70%)​

​

​